Gilead Sciences GILD
NASDAQ GILD
$157.19 +3.62 (+2.36%)
At close: Oct 22, 2026 · 4:00 PM EDT

Gilead Sciences (GILD) Convertible Debt (2009 - 2010)

Updated

Gilead Sciences (GILD) posted Convertible Debt of $2.84 billion for Q4 2010, up 145.7% from $1.16 billion a year earlier and up 0.7% from the prior quarter.

Analysis

Gilead Sciences (GILD) Convertible Debt (2009 - 2010) Analysis & Trends

Since Q2 2009, Gilead Sciences has reported Convertible Debt for 6 quarters.

  • In prior years, Gilead Sciences' Convertible Debt was $1.16 billion in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Vertex Pharmaceuticals 135.25 Bn 107.26 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 2.84 Bn
Sep 30, 2010 2.82 Bn
Mar 31, 2010 1.17 Bn
Dec 31, 2009 1.16 Bn
Sep 30, 2009 1.14 Bn
Jun 30, 2009 1.13 Bn
API Access

Gilead Sciences Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=GILD&period=max&api_key=YOUR_API_KEY